forpolicymakers
europeanunion
Go back to European Union page
Primary purpose: To examine and analyze the commercial determinants of cancer control policy and provide insights into how to govern them across the cancer continuum for the benefit of governments and the international community.
Sponsor, manager or home institution: European Observatory on Health Systems and Policies; Eurohealth.
Type of information: The dark side of the commercial determinants of cancer policy; Countering corporate tactics for better cancer prevention; The commercial drivers of cancer screening; Non-pharmaceutical technologies in cancer care; Commerical determinants of cancer medicines; Commercial and social determinants in palliative care; The role of governments and international agencies; Ethical questions surrounding the commercial determinants of health. Click here to learn more.
Data level: global level.
Cancer Areas of Interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
Mouth
Throat
Oropharynx
Nasopharynx
Hypopharynx
Larynx
Salivary glands
Lips
Tonsils
base of tongue
Voice box
Esophagus
Stomach
Small intestine
Large intestine
Colon
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Lung
Trachea
Bronchi
Pleura
Mediastinum
Bone
Cartilage
Osteosarcoma
Ewings sarcoma
Skin
Melanoma
Scalp
Lips
Hands
Feet
Muscle
Fat
Tendon
Ligament
Blood vessels
Connective tissue
Sarcoma
Angiosarcoma
Liposarcoma
Lobular
Breast
Nipple
Areola
Ductal
Vulva
Vagina
Cervix
Uterus
Ovary
Fallopian tubes
Endometrium
Prostate
Testicles
Penis
Kidney
Ureter
Bladder
Urethra
Eye
Brain
Spinal cord
Thyroid gland
Parathyroid
Adrenal glands
Pituitary gland
Pancreas
Thymus gland
Peritoneum
Pericardium
Retroperitoneum
Mesothelium
Blood
Bone marrow
Lymph nodes
Spleen
Leukemia
dataOwner::European Observatory on Health Systems and Policies
dataOwner::Eurohealth
availableVariable::screening|cancer prevention
availableVariable::palliative care
dataLevel::global level
isReport
hasCancerType::C00-C97: All cancer types
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C14: Mouth/throat cancers
hasCancerType::C15-C26: Digestive system cancers
hasCancerType::C30-C39: Lung/chest cancers
hasCancerType::C40-C41: Bone cancers
hasCancerType::C43-C44: Skin cancers/melanoma
hasCancerType::C45-C49: Soft tissue cancer
hasCancerType::C50: Breast cancer
hasCancerType::C51-C58: Female genitalia cancers
hasCancerType::C60-C63: Male genitalia cancer
hasCancerType::C64-C68: Urinary system cancers
hasCancerType::C69-C72: Eye and brain cancer
hasCancerType::C73-C75: Thyroid and other gland cancers
hasCancerType::C76-C80: Cancers of unknown or unspecified areas
hasCancerType::C81-C96: Cancers of the blood and immune system
hasCancerType::C97-C97: Cancers in multiple locations from the start
